Stifel Financial’s Filana Therapeutics FLNA Stock Holding History

Stifel Financial’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89.3K	Buy	+75,000	New	+$107K	﹤0.01%	3625
2022 Q3	–	Sell	-87,175	Closed	-$2.45M	–	3372
2022 Q2	$2.45M	Sell	87,175 -2,872	-3%	-$72.5K	﹤0.01%	1370
2022 Q1	$3.34M	Buy	90,047 +1,402	+2%	+$59.4K	﹤0.01%	1278
2021 Q4	$3.87M	Buy	88,645 +33,978	+62%	+$1.78M	0.01%	1211
2021 Q3	$3.39M	Sell	54,667 -4,511	-8%	-$376K	0.01%	1241
2021 Q2	$5.06M	Buy	59,178 +4,300	+8%	+$230K	0.01%	1024
2021 Q1	$2.47M	Buy	+54,878	New	+$2.16M	﹤0.01%	1386

Other funds holding FLNA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Stifel Financial's FLNA Position: Q2 2026 in Review

Stifel Financial opened a new position in Filana Therapeutics (FLNA) in Q2 2026: 75,000 shares worth $89.3K. The stake represents ﹤0.01% of the portfolio and ranks #3625 among its holdings. This is a return to the name: Stifel Financial previously reported a position in FLNA as recently as Q2 2022.

Stifel Financial first reported a position in FLNA in Q1 2021 and has held it in 7 quarters since. The position peaked at $5.06M in Q2 2021. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

Stifel Financial held 75,000 shares of Filana Therapeutics worth $89.3K as of Q2 2026.
Filana Therapeutics was a new Stifel Financial position in Q2 2026.
Filana Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3625 holding.
Stifel Financial first reported a position in Filana Therapeutics in Q1 2021 and has held it in 7 quarters since.
Stifel Financial's Filana Therapeutics position peaked at $5.06M in Q2 2021.
84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.